Page last updated: 2024-10-26

doxapram and Breathlessness

doxapram has been researched along with Breathlessness in 2 studies

Doxapram: A central respiratory stimulant with a brief duration of action. (From Martindale, The Extra Pharmocopoeia, 30th ed, p1225)
doxapram : A member of the class of pyrrolidin-2-ones that is N-ethylpyrrolidin-2-one in which both of the hydrogens at the 3 position (adjacent to the carbonyl group) are substituted by phenyl groups, and one of the hydrogens at the 4 position is substituted by a 2-(morpholin-4-yl)ethyl group. A central and respiratory stimulant with a brief duration of action, it is used (generally as the hydrochloride or the hydrochloride hydrate) as a temporary treatment of acute respiratory failure, particularly when superimposed on chronic obstructive pulmonary disease, and of postoperative respiratory depression. It has also been used for treatment of postoperative shivering.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ebihara, S1
Ogawa, H1
Sasaki, H1
Hida, W1
Kikuchi, Y1
Masuda, A1

Trials

1 trial available for doxapram and Breathlessness

ArticleYear
Doxapram and perception of dyspnea.
    Chest, 2002, Volume: 121, Issue:4

    Topics: Adult; Doxapram; Dyspnea; Humans; Hypoxia; Male; Middle Aged; Oxygen; Respiratory System Agents; Ris

2002

Other Studies

1 other study available for doxapram and Breathlessness

ArticleYear
[Dyspnea sensation and chemical control of breathing].
    Nihon Kyobu Shikkan Gakkai zasshi, 1992, Volume: 30, Issue:4

    Topics: Acclimatization; Breath Tests; Carbon Dioxide; Chemoreceptor Cells; Doxapram; Dyspnea; Humans; Oxyge

1992